Advertisement
Australia markets close in 4 hours 51 minutes
  • ALL ORDS

    7,849.30
    -88.20 (-1.11%)
     
  • ASX 200

    7,589.90
    -93.10 (-1.21%)
     
  • AUD/USD

    0.6528
    +0.0004 (+0.07%)
     
  • OIL

    83.90
    +0.33 (+0.39%)
     
  • GOLD

    2,339.70
    -2.80 (-0.12%)
     
  • Bitcoin AUD

    98,031.92
    -717.13 (-0.73%)
     
  • CMC Crypto 200

    1,385.09
    +2.52 (+0.18%)
     
  • AUD/EUR

    0.6083
    +0.0010 (+0.17%)
     
  • AUD/NZD

    1.0944
    -0.0013 (-0.12%)
     
  • NZX 50

    11,882.07
    -64.36 (-0.54%)
     
  • NASDAQ

    17,430.50
    -96.30 (-0.55%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • Dow Jones

    38,085.80
    -375.12 (-0.98%)
     
  • DAX

    17,917.28
    -171.42 (-0.95%)
     
  • Hang Seng

    17,284.54
    0.00 (0.00%)
     
  • NIKKEI 225

    37,636.99
    +8.51 (+0.02%)
     

How GSK’s Consumer Healthcare Segment Fared in Q1 2018

How GSK’s Consumer Healthcare Segment Fared in Q1 2018

GlaxoSmithKline’s (GSK) Consumer Healthcare segment includes various products for oral health, wellness, nutrition, and skin health. The Consumer Healthcare segment reported a 3% fall in its YoY (year-over-year) revenue to ~2.0 billion pounds in Q1 2018 compared to Q1 2017.